Point72 Asset Management L.P. reduced its holdings in shares of Abercrombie & Fitch Co. (NYSE:ANF – Free Report) by 73.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,991 shares of the apparel retailer’s stock after selling 94,509 shares during the period. Point72 Asset Management L.P. owned approximately 0.07% of Abercrombie & Fitch worth $6,223,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ANF. Matrix Trust Co acquired a new position in shares of Abercrombie & Fitch during the second quarter valued at about $35,000. Quarry LP increased its holdings in Abercrombie & Fitch by 156.0% in the 2nd quarter. Quarry LP now owns 279 shares of the apparel retailer’s stock worth $50,000 after buying an additional 170 shares during the period. CWM LLC increased its stake in shares of Abercrombie & Fitch by 242.6% in the second quarter. CWM LLC now owns 531 shares of the apparel retailer’s stock worth $94,000 after acquiring an additional 376 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in Abercrombie & Fitch by 8,914.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 631 shares of the apparel retailer’s stock valued at $112,000 after purchasing an additional 624 shares during the last quarter. Finally, Plato Investment Management Ltd raised its stake in shares of Abercrombie & Fitch by 66.1% during the 2nd quarter. Plato Investment Management Ltd now owns 741 shares of the apparel retailer’s stock valued at $132,000 after buying an additional 295 shares during the last quarter.
Analysts Set New Price Targets
A number of analysts have recently commented on the company. Jefferies Financial Group upped their target price on Abercrombie & Fitch from $215.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. raised shares of Abercrombie & Fitch from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $167.00 to $194.00 in a research note on Monday, July 22nd. Citigroup upgraded Abercrombie & Fitch from a “neutral” rating to a “buy” rating and set a $190.00 price target for the company in a research note on Friday, August 30th. Telsey Advisory Group reiterated an “outperform” rating and set a $190.00 price target on shares of Abercrombie & Fitch in a research report on Wednesday, September 11th. Finally, Argus downgraded Abercrombie & Fitch from a “buy” rating to a “hold” rating in a research note on Thursday, July 11th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $176.57.
Insider Buying and Selling at Abercrombie & Fitch
In other news, CFO Scott D. Lipesky sold 9,000 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $146.80, for a total transaction of $1,321,200.00. Following the completion of the sale, the chief financial officer now owns 106,455 shares in the company, valued at approximately $15,627,594. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Abercrombie & Fitch news, CFO Scott D. Lipesky sold 9,000 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $146.80, for a total transaction of $1,321,200.00. Following the completion of the sale, the chief financial officer now owns 106,455 shares of the company’s stock, valued at $15,627,594. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Helen Mccluskey sold 3,500 shares of Abercrombie & Fitch stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $139.38, for a total value of $487,830.00. Following the completion of the sale, the director now owns 37,470 shares in the company, valued at approximately $5,222,568.60. The disclosure for this sale can be found here. Insiders have sold 31,541 shares of company stock worth $4,310,256 in the last ninety days. 3.77% of the stock is owned by insiders.
Abercrombie & Fitch Trading Down 3.0 %
Shares of NYSE ANF opened at $135.71 on Wednesday. The stock has a market cap of $6.94 billion, a PE ratio of 16.88 and a beta of 1.50. Abercrombie & Fitch Co. has a 12-month low of $53.16 and a 12-month high of $196.99. The company has a 50-day moving average of $145.86 and a 200 day moving average of $147.56.
Abercrombie & Fitch (NYSE:ANF – Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The apparel retailer reported $2.50 EPS for the quarter, beating the consensus estimate of $2.14 by $0.36. The firm had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Abercrombie & Fitch had a return on equity of 47.35% and a net margin of 10.76%. On average, sell-side analysts forecast that Abercrombie & Fitch Co. will post 10.26 EPS for the current fiscal year.
About Abercrombie & Fitch
Abercrombie & Fitch Co, through its subsidiaries, operates as an omnichannel retailer in the United States, Europe, the Middle East, Asia, the Asia-Pacific, Canada, and internationally. The company offers an assortment of apparel, personal care products, and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, Hollister, and Gilly Hicks brands.
Recommended Stories
- Five stocks we like better than Abercrombie & Fitch
- Comparing and Trading High PE Ratio Stocks
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Bank Stocks – Best Bank Stocks to Invest In
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Abercrombie & Fitch Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abercrombie & Fitch and related companies with MarketBeat.com's FREE daily email newsletter.